Page last updated: 2024-09-05

dexketoprofen trometamol and Bone Cancer

dexketoprofen trometamol has been researched along with Bone Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Luna-Bertos, E; García-Martínez, O; Guildford, A; Ramos-Torrecillas, J; Ruiz, C; Santin, M1
Busquets, C; Camba, MA; Castro, A; Contreras, D; Gálvez, R; Herrera, J; Rodríguez, MJ1

Trials

1 trial(s) available for dexketoprofen trometamol and Bone Cancer

ArticleYear
Double-blind evaluation of short-term analgesic efficacy of orally administered dexketoprofen trometamol and ketorolac in bone cancer pain.
    Pain, 2003, Volume: 104, Issue:1-2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Chi-Square Distribution; Double-Blind Method; Female; Humans; Ketoprofen; Ketorolac; Male; Middle Aged; Pain; Statistics, Nonparametric; Tromethamine

2003

Other Studies

1 other study(ies) available for dexketoprofen trometamol and Bone Cancer

ArticleYear
Therapeutic doses of nonsteroidal anti-inflammatory drugs inhibit osteosarcoma MG-63 osteoblast-like cells maturation, viability, and biomineralization potential.
    TheScientificWorldJournal, 2013, Volume: 2013

    Topics: Alkaline Phosphatase; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Differentiation; Aspirin; Bone Neoplasms; Bone Remodeling; Calcification, Physiologic; Cell Differentiation; Cell Line, Tumor; Cell Survival; Collagen; Culture Media; Dipyrone; Extracellular Matrix; Flow Cytometry; Humans; Ketoprofen; Ketorolac; Minerals; Osteoblasts; Osteosarcoma; Phagocytosis; Tromethamine

2013